# Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

> **NCT04583488** · PHASE1 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 2 (actual)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Intraperitoneal docetaxel

## Key facts

- **NCT ID:** NCT04583488
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-01
- **Primary completion:** 2024-08-06
- **Final completion:** 2024-08-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** PI left institution
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04583488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04583488, "Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04583488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*